These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 10493532

  • 21. [Influence of transfection of sense- and antisense-TGF beta 1 gene on human pulmonary giant cell carcinoma cell proliferation].
    Yang H, Lu Y, Shen H.
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):89-92. PubMed ID: 10743067
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation.
    Hafez MM, Infante D, Winawer S, Friedman E.
    Cell Growth Differ; 1990 Dec; 1(12):617-26. PubMed ID: 2288877
    [Abstract] [Full Text] [Related]

  • 24. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.
    Hsu S, Huang F, Hafez M, Winawer S, Friedman E.
    Cell Growth Differ; 1994 Mar; 5(3):267-75. PubMed ID: 8018559
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
    Picon A, Gold LI, Wang J, Cohen A, Friedman E.
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
    [Abstract] [Full Text] [Related]

  • 29. Mouse embryonic stem cells with aberrant transforming growth factor beta signalling exhibit impaired differentiation in vitro and in vivo.
    Goumans MJ, Ward-van Oostwaard D, Wianny F, Savatier P, Zwijsen A, Mummery C.
    Differentiation; 1998 Jul; 63(3):101-13. PubMed ID: 9697304
    [Abstract] [Full Text] [Related]

  • 30. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y, Banerji SS, Liu Y, Li W, Liang J, Soule HD, Pauley RJ, Willson JK, Zborowska E, Brattain MG.
    J Cell Physiol; 1998 Aug; 176(2):424-34. PubMed ID: 9648930
    [Abstract] [Full Text] [Related]

  • 31. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells.
    Periyasamy S, Sun L, Gentry LE, Brattain MG.
    J Cell Physiol; 1996 Sep; 168(3):711-20. PubMed ID: 8816926
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B, Groth S, Sebens Müerköster S, Sipos B, Schäfer H, Kalthoff H, Fändrich F, Ungefroren H.
    Oncogene; 2007 Jul 19; 26(33):4850-62. PubMed ID: 17297450
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
    Halder SK, Beauchamp RD, Datta PK.
    Exp Cell Res; 2005 Jul 01; 307(1):231-46. PubMed ID: 15922743
    [Abstract] [Full Text] [Related]

  • 36. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1.
    Williams AC, Browne SJ, Manning AM, Daffada P, Collard TJ, Paraskeva C.
    Oncogene; 1994 May 01; 9(5):1479-85. PubMed ID: 8152811
    [Abstract] [Full Text] [Related]

  • 37. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
    Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, Liu XQ, Hauser J, Brattain MG.
    Cancer Res; 2008 May 01; 68(9):3152-60. PubMed ID: 18451140
    [Abstract] [Full Text] [Related]

  • 38. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
    Jiang W, Tillekeratne MP, Brattain MG, Banerji SS.
    Biochemistry; 1997 Dec 02; 36(48):14786-93. PubMed ID: 9402753
    [Abstract] [Full Text] [Related]

  • 39. Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET.
    Lynch MJ, Pelosi L, Carboni JM, Merwin J, Coleman K, Wang RC, Lin PF, Henry DL, Brattain MG.
    Cancer Res; 1993 Sep 01; 53(17):4041-7. PubMed ID: 8358733
    [Abstract] [Full Text] [Related]

  • 40. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.
    Gorska AE, Joseph H, Derynck R, Moses HL, Serra R.
    Cell Growth Differ; 1998 Mar 01; 9(3):229-38. PubMed ID: 9543389
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.